TY - JOUR
T1 - Modulation of a 40-kDa catecholamine regulated protein by dopamine receptor antagonists
AU - Sharan, Niki
AU - Nair, Venugopalan D.
AU - Mishra, Ram K.
N1 - Funding Information:
This work was supported by the Medical Research Council of Canada (MRC MT6237). We thank Ms. Cia Barlas for her helpful discussions. VDN is a recipient of a post-doctoral fellowship from Ontario Mental Health Foundation. RKM is a senior fellowship awardee of the Ontario Mental Health Foundation.
PY - 2001/2/9
Y1 - 2001/2/9
N2 - Previous reports have shown that catecholamine regulated proteins (CRP) are central nervous system specific and covalently bind to catecholamines. In the present study, we report the subcellular localization and differential modulation of a 40-kDa catecholamine regulated protein (CRP40) by dopamine D1 and D2 receptor antagonists. CRP40 was found to be localized with nuclear and synaptosomal/mitochondrial and fractions. Chronic treatment with dopamine D2 receptor antagonist haloperidol in rats significantly increased the levels of CRP40 in the striatum, whereas, chronic R(+)-7-chloro-8-hydroxy-3-methyl-1-phenyl-2, 3, 4, 5-tetrahydro-1H-3-benzazep ine (SCH 23390) dopamine D1 receptor antagonist administration significantly decreased striatal CRP40 levels. Moreover, acute haloperidol treatment did not alter the levels of CRP40 in any of the brain regions. Despite a sequence homology with the heat shock protein 70 (HSP70), levels of HSP70 remained unchanged after either drug treatment, suggesting a distinct function of CRP40 than HSP70. These results further suggest that CRP40 play an important role in dopaminergic neuronal function and the dopamine D1 receptor-mediated signaling pathway may be involved in the regulation of CRP40.
AB - Previous reports have shown that catecholamine regulated proteins (CRP) are central nervous system specific and covalently bind to catecholamines. In the present study, we report the subcellular localization and differential modulation of a 40-kDa catecholamine regulated protein (CRP40) by dopamine D1 and D2 receptor antagonists. CRP40 was found to be localized with nuclear and synaptosomal/mitochondrial and fractions. Chronic treatment with dopamine D2 receptor antagonist haloperidol in rats significantly increased the levels of CRP40 in the striatum, whereas, chronic R(+)-7-chloro-8-hydroxy-3-methyl-1-phenyl-2, 3, 4, 5-tetrahydro-1H-3-benzazep ine (SCH 23390) dopamine D1 receptor antagonist administration significantly decreased striatal CRP40 levels. Moreover, acute haloperidol treatment did not alter the levels of CRP40 in any of the brain regions. Despite a sequence homology with the heat shock protein 70 (HSP70), levels of HSP70 remained unchanged after either drug treatment, suggesting a distinct function of CRP40 than HSP70. These results further suggest that CRP40 play an important role in dopaminergic neuronal function and the dopamine D1 receptor-mediated signaling pathway may be involved in the regulation of CRP40.
KW - Catecholamine regulated protein
KW - Dopamine
KW - Haloperidol
KW - Heat shock protein
KW - Neurodegenerative disease
KW - SCH 23390
UR - https://www.scopus.com/pages/publications/0035830623
U2 - 10.1016/S0014-2999(01)00736-1
DO - 10.1016/S0014-2999(01)00736-1
M3 - Article
C2 - 11173065
AN - SCOPUS:0035830623
SN - 0014-2999
VL - 413
SP - 73
EP - 79
JO - European Journal of Pharmacology
JF - European Journal of Pharmacology
IS - 1
ER -